// App-Quantinova.ai

TCT-316 : Clinical Outcomes After Left Main Coronary Artery Revascularization by PCI or CABG in Current, Former, and Never Smokers: Analysis From the EXCEL Trial

Researchers

Presenter

  • Bahira Shahim

Principal Investigators

  • Bjorn Redfors

  • Shmuel Chen

  • Marie-Claude Morice

  • David Taggart

  • Bernard Gersh

  • John Puskas

  • David Kandzari

  • Bela Merkely

  • Aaron Crowley

  • Patrick Serruys

  • A. Pieter Kappetein

  • Joseph Sabik

  • Ori Ben-Yehuda

  • Gregg Stone

Medical Centers

  • Mayo Clinic, Rochester, Minnesota

  • Piedmont Heart Institute, Atlanta, Georgia

  • Semmelweis University, Cardiac and Vascular Center, Budapest, Hungary

  • Cardiovascular Research Foundation, New York, New York, USA

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio

  • Mount Sinai, New York, New York

  • Medtronic, Mounds View, Minnesota

  • Imperial College, London, United Kingdom

  • Cardiovascular Research Foundation, Columbia University Medical Center/New York–Presbyterian Hospital, New York, New York

  • CERC, Massy, France

  • Oxford University, Oxford, United Kingdom

Locations

  • United States

  • United Kingdom

  • Hungary

  • France

  • Georgia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved